Abstract
The cDNAs encoding for three subtypes of adrenergic receptors, α1A-, α1B- and α1D-ARs, were cloned and expressed in HEK 293 cells. Expression of α1A- and α1B-AR subtypes in HEK 293 cells was stable even with increased passages but that of α1D-AR was not. Cellular localization studies using immunofluorescence and flow cytometry revealed that expression of α1A- and α1B-ARs was primarily localized on the cell membrane whereas expression of α1D-AR was␣predominantly intracellular. Our studies clearly demonstrated that the culturing of the recombinant cell lines expressing α1D-AR in charcoal/dextran treated fetal bovine serum (FBS) resulted in targeting of α1D-AR to the cell membrane and thus, significantly improving its stability and availability for ligand binding studies.
Similar content being viewed by others
References
Cotecchia S, Schwinn DA, Randall RR, Lefkowitz RJ, Caron MG, Kobilka BK (1988) Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. Proc Natl Acad Sci USA 85:7159–7163
Garcia-Sainz JA, Torres-Padilla ME (1999) Modulation of basal intracellular calcium by inverse agonists and phorbol myristate acetate in rat-1 fibroblasts stably expressing α1D adrenoceptors. FEBS Lett 443:277–281
Hague C, Uberti MA, Chen Z, Hall RA, Minneman KP (2004a) Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors. J Biol Chem 279: 15541–15549
Hague C, Chen Z, Pupo AS, Schulte NA, Toews ML, Minneman KP (2004b) The N terminus of human α1D-adrenergic receptor prevents cell surface expression. J Pharmacol Exp Ther 309:388–397
Hirasawa A, Sugawara T, Awaji T, Tsumaya K, Ito H, Tsujimoto G (1997) Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. Mol Pharmacol 52:52764–52770
Hirasawa A, Tsumaya K, Awaji T, Shibata K, Homma N, Shinomiya T, Tsujimoto G (1996) Flow cytometry analysis of α1-adrenoceptor subtypes. FEBS Lett 386:141–148
Hrometz SL, Edelmann SE, McCune DF, Olges JR, Hadley RW, Perez DM, Piascik MT (1999) Expression of multiple alpha1-adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. J Pharmacol Exp Ther 290:452–463
Khattar SK, Bora RS, Priyadarsiny P, Gupta D, Khanna A, Narayanan KL, Babu V, Chugh A, Saini KS (2006) High level stable expression of pharmacologically active human m1–m5 muscarinic receptor subtypes in Mammalian cells. Biotechnol Lett 28:121–129
Lindquist DL, de Alarcon PA (1987) Charcoal-dextran treatment of fetal bovine serum removes an inhibitor of human CFU-megakaryocytes. Exp Hematol 15:234–238
Lomasney JW, Cotecchia S, Lorenz W, Leung WY, Schwinn DA, Yang-Feng TL, Brownstein M, Lefkowitz RJ, Caron MG (1991) Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5. J Biol Chem 266:6365–6369
McCune DF, Edelmann SE, Olges JR, Post GR, Waldrop BA, Waugh DJ, Perez DM, Piascik MT (2000) Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonists. Mol Pharmacol 57:659–666
Perez DM, Piascik MT, Graham RM (1991) Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA. Mol Pharmacol 40:876–883
Perez DM, Piascik MT, Malik N, Gaivin R, Graham RM (1994) Cloning, expression and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype. Mol Pharmacol 46:823–831
Piascik MT, Perez DM (2001) Alpha1-adrenergic receptors: new insights and directions. J Pharmacol Exp Ther 298:403–410
Pupo AS, Uberti MA, Minneman KP (2003) N-terminal truncation of human of α1D-adrenoceptors increases expression of binding sites but not protein. Eur J Pharmacol 462:1–8
Scheer A, Fanelli F, Costa T, De Benedetti PG, Cotecchia S (1997) The activation process of the α1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci USA 94:808–813
Schwinn DA, Lomasney JW, Lorenz W, Szklut PJ, Fremeau RT Jr, Yang-Feng TL, Caron MG, Lefkowitz RJ, Cotecchia S (1990) Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. J Biol Chem 265:8183–8189
Sugawara T, Hirasawa A, Hashimoto K, Tsujimoto G (2002) Differences in the subcellular localization of α1-adrenoceptor subtypes can affect the subtype selectivity of drugs in a study with the fluorescent ligand BODIPY FL-prazosin. Life Sci. 70:2113–2124
Terzic A, Puceat M, Vassort G, Vogel SM (1993) Cardiac alpha 1-adrenoceptors: an overview. Pharmacol Rev 45:147–175
Tsang LL, Chan LN, Liu CQ, Chan HC (2001) Effect of phenol red and steroid hormones on cystic fibrosis transmembrane conductance regulator in mouse endometrial epithelial cells. Cell Biol Int 25:1021–1024
Uberti MA, Hall RA, Minneman KP (2003) Subtype-specific dimerization of alpha 1 adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 64:1379–1390
Vicentic A, Robeva A, Rogge G, Uberti M, Minneman KP (2002) Biochemistry and pharmacology of epitope-tagged alpha-1-adrenergic receptor subtypes. J Pharmacol Exp Ther 302:58–65
Zhong H, Minneman KP (1999) Alpha1-adrenoceptor subtypes. Eur J Pharmacol 375:261–276
Acknowledgement
We thank Dr. Kedar Padmakar Purnapatre for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Sunil M. Khattar, Roop Singh Bora and Priyanka Priyadarsiny contributed equally to this work.
Rights and permissions
About this article
Cite this article
Khattar, S.K., Bora, R.S., Priyadarsiny, P. et al. Molecular cloning, stable expression and cellular localization of human α1-adrenergic receptor subtypes: effect of charcoal/dextran treated serum on expression and localization of α1D -adrenergic receptor. Biotechnol Lett 28, 1731–1739 (2006). https://doi.org/10.1007/s10529-006-9148-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-006-9148-x